Fidocure
FidoCure is a translational precision-medicine service for canine cancer, developed by One Health Company and backed by a16z. It combines next-generation genomic sequencing of a dog's tumor at a CLIA-certified (human-grade) lab with tumor profiling and an AI-driven data platform to identify cancer-driving mutations, then recommends personalized targeted therapeutics that veterinarians can prescribe. FidoCure has guided treatment for thousands of dogs across roughly 1,350 clinics and maintains the largest proprietary canine cancer dataset, underpinning peer-reviewed research with Stanford, the Broad Institute, Tufts, and the University of Georgia. FidoCure operates as a veterinarian-facing clinical service rather than a public developer API; this profile captures its public identity, portal, and domain-security posture for the API Evangelist network.
Fidocure is profiled on the APIs.io network. Tagged areas include Company, Precision Medicine, Veterinary, Genomics, and Oncology.
Fidocure’s developer surface includes engineering blog, support, and 8 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Get Started 1
Portal, sign-up, and the first successful call
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 5
The organization behind the API